You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 11, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Jeffrey L Weinstein1, Muneeb Ahmed1
11 Division of Vascular and Interventional Radiology, Department of Radiology, WCC 308-F, Beth Israel Deaconess Medical Center/Harvard Medical School, 1 Deaconess Rd, Boston, MA 02215.
Percutaneous ablation is a key treatment for early-stage hepatocellular carcinoma (HCC), providing survival rates similar to surgery for small tumors. Advanced techniques and combination therapies enhance outcomes for larger lesions.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: